245 related articles for article (PubMed ID: 12176878)
1. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
McSweeney PA; Nash RA; Sullivan KM; Storek J; Crofford LJ; Dansey R; Mayes MD; McDonagh KT; Nelson JL; Gooley TA; Holmberg LA; Chen CS; Wener MH; Ryan K; Sunderhaus J; Russell K; Rambharose J; Storb R; Furst DE
Blood; 2002 Sep; 100(5):1602-10. PubMed ID: 12176878
[TBL] [Abstract][Full Text] [Related]
2. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
Nash RA; McSweeney PA; Crofford LJ; Abidi M; Chen CS; Godwin JD; Gooley TA; Holmberg L; Henstorf G; LeMaistre CF; Mayes MD; McDonagh KT; McLaughlin B; Molitor JA; Nelson JL; Shulman H; Storb R; Viganego F; Wener MH; Seibold JR; Sullivan KM; Furst DE
Blood; 2007 Aug; 110(4):1388-96. PubMed ID: 17452515
[TBL] [Abstract][Full Text] [Related]
3. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
Nash RA; Bowen JD; McSweeney PA; Pavletic SZ; Maravilla KR; Park MS; Storek J; Sullivan KM; Al-Omaishi J; Corboy JR; DiPersio J; Georges GE; Gooley TA; Holmberg LA; LeMaistre CF; Ryan K; Openshaw H; Sunderhaus J; Storb R; Zunt J; Kraft GH
Blood; 2003 Oct; 102(7):2364-72. PubMed ID: 12763935
[TBL] [Abstract][Full Text] [Related]
4. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations.
Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I
J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352
[TBL] [Abstract][Full Text] [Related]
5. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
Burt RK; Traynor AE; Pope R; Schroeder J; Cohen B; Karlin KH; Lobeck L; Goolsby C; Rowlings P; Davis FA; Stefoski D; Terry C; Keever-Taylor C; Rosen S; Vesole D; Fishman M; Brush M; Mujias S; Villa M; Burns WH
Blood; 1998 Nov; 92(10):3505-14. PubMed ID: 9808541
[TBL] [Abstract][Full Text] [Related]
6. [The role and place of high-dose immunosuppressive therapy and autologous transplantation of hematopoietic stem cells for autoimmune diseases].
Makarov SV; Rossiev VA; Mishchenko OV; Kozlov VA; Semagina OV; Alexandrova IY; Grishina GV; Minaev YL
Ter Arkh; 2016; 88(1):53-59. PubMed ID: 26978610
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract][Full Text] [Related]
8. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
9. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.
Nash RA; Hutton GJ; Racke MK; Popat U; Devine SM; Griffith LM; Muraro PA; Openshaw H; Sayre PH; Stüve O; Arnold DL; Spychala ME; McConville KC; Harris KM; Phippard D; Georges GE; Wundes A; Kraft GH; Bowen JD
JAMA Neurol; 2015 Feb; 72(2):159-69. PubMed ID: 25546364
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
[TBL] [Abstract][Full Text] [Related]
11. Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation.
Storek J; Zhao Z; Liu Y; Nash R; McSweeney P; Maloney DG
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1373-9. PubMed ID: 19041059
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring?
Burt RK; Oyama Y; Traynor A; Quigley K; Brush M; Rodriguez J; Barr WG
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S65-7. PubMed ID: 12931246
[TBL] [Abstract][Full Text] [Related]
13. A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation.
Leng XM; Zhao Y; Zhou DB; Situ H; Li TS; Shen T; Zhao YQ; Zeng XF; Zhang FC; Dong Y; Tang FL
Chin Med Sci J; 2005 Sep; 20(3):159-65. PubMed ID: 16261884
[TBL] [Abstract][Full Text] [Related]
14. Stem cell transplantation for systemic sclerosis.
Bruera S; Sidanmat H; Molony DA; Mayes MD; Suarez-Almazor ME; Krause K; Lopez-Olivo MA
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011819. PubMed ID: 35904231
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.
Farge D; Marolleau JP; Zohar S; Marjanovic Z; Cabane J; Mounier N; Hachulla E; Philippe P; Sibilia J; Rabian C; Chevret S; Gluckman E;
Br J Haematol; 2002 Dec; 119(3):726-39. PubMed ID: 12437652
[TBL] [Abstract][Full Text] [Related]
16. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Sullivan KM; Goldmuntz EA; Keyes-Elstein L; McSweeney PA; Pinckney A; Welch B; Mayes MD; Nash RA; Crofford LJ; Eggleston B; Castina S; Griffith LM; Goldstein JS; Wallace D; Craciunescu O; Khanna D; Folz RJ; Goldin J; St Clair EW; Seibold JR; Phillips K; Mineishi S; Simms RW; Ballen K; Wener MH; Georges GE; Heimfeld S; Hosing C; Forman S; Kafaja S; Silver RM; Griffing L; Storek J; LeClercq S; Brasington R; Csuka ME; Bredeson C; Keever-Taylor C; Domsic RT; Kahaleh MB; Medsger T; Furst DE;
N Engl J Med; 2018 Jan; 378(1):35-47. PubMed ID: 29298160
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
18. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease.
Tsukamoto H; Nagafuji K; Horiuchi T; Miyamoto T; Aoki K; Takase K; Henzan H; Himeji D; Koyama T; Miyake K; Inoue Y; Nakashima H; Otsuka T; Tanaka Y; Nagasawa K; Harada M
Ann Rheum Dis; 2006 Apr; 65(4):508-14. PubMed ID: 16126798
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of antithymocyte globulin in systemic sclerosis.
Matteson EL; Shbeeb MI; McCarthy TG; Calamia KT; Mertz LE; Goronzy JJ
Arthritis Rheum; 1996 Jul; 39(7):1132-7. PubMed ID: 8670321
[TBL] [Abstract][Full Text] [Related]
20. Autologous stem cell transplantation in the treatment of refractory rheumatoid arthritis.
Kim KC; Lee IH; Choi JH; Oh MR; Ahn MJ; Kim SY
J Korean Med Sci; 2002 Feb; 17(1):129-32. PubMed ID: 11850603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
